DE HB16 | 2023-2024 | 152nd General Assembly
Status
Completed Legislative Action
Spectrum: Moderate Partisan Bill (Democrat 20-3)
Status: Passed on October 9 2024 - 100% progression
Action: 2024-10-09 - Signed by Governor
Text: Latest bill text (Engrossed) [HTML]
Spectrum: Moderate Partisan Bill (Democrat 20-3)
Status: Passed on October 9 2024 - 100% progression
Action: 2024-10-09 - Signed by Governor
Text: Latest bill text (Engrossed) [HTML]
Summary
This Act requires that Medicaid and State employee health plans cover: (1) ovarian cancer monitoring tests for women treated for ovarian cancer; and (2) annual screening tests for women at risk for ovarian cancer.
Title
An Act To Amend Titles 29 And 31 Of The Delaware Code Relating To Ovarian Cancer.
Sponsors
Roll Calls
2024-06-30 - Senate - Senate Third Reading (Y: 21 N: 0 NV: 0 Abs: 0) [PASS]
2024-06-11 - House - House Third Reading (Y: 39 N: 0 NV: 0 Abs: 2) [PASS]
2024-06-11 - House - House Third Reading (Y: 39 N: 0 NV: 0 Abs: 2) [PASS]
History
| Date | Chamber | Action |
|---|---|---|
| 2024-10-09 | Signed by Governor | |
| 2024-06-30 | Passed By Senate. Votes: 21 YES | |
| 2024-06-26 | Reported Out of Committee (Finance) in Senate with 4 On Its Merits | |
| 2024-06-18 | Assigned to Finance Committee in Senate | |
| 2024-06-18 | Reported Out of Committee (Health & Social Services) in Senate with 5 On Its Merits | |
| 2024-06-11 | Assigned to Health & Social Services Committee in Senate | |
| 2024-06-11 | Passed By House. Votes: 39 YES 2 ABSENT | |
| 2024-06-11 | Amendment HA 1 to HB 16 - Passed In House by Voice Vote | |
| 2024-05-22 | Reported Out of Committee (Appropriations) in House with 1 Favorable, 5 On Its Merits | |
| 2024-05-21 | Amendment HA 1 to HB 16 - Introduced and Placed With Bill | |
| 2024-03-19 | Assigned to Appropriations Committee in House | |
| 2024-03-13 | Reported Out of Committee (Health & Human Development) in House with 10 Favorable, 2 On Its Merits | |
| 2024-02-29 | Introduced and Assigned to Health & Human Development Committee in House |
